Probiotic, Vitamin D Supplementation Tied to Benefits With Schizophrenia
By Lori Solomon HealthDay Reporter
FRIDAY, April 12, 2024 -- Supplementation with probiotics and vitamin D may have beneficial effects on cognitive function in patients with schizophrenia, according to a study published online April 10 in Neuropsychopharmacology Reports.
Aida Mohammadi, from University of Social Welfare and Rehabilitation Sciences in Iran, and colleagues evaluated the effects of probiotic/vitamin D (400 IU) supplementation on cognitive function and disease severity in 69 patients (aged 18 to 65 years) with schizophrenia.
The researchers found that the Montreal Cognitive Assessment (MoCA) score increased by 1.96 units in the probiotic-containing supplement group versus the group receiving placebo. Further, the percentage of individuals with a MoCA score ≥26 rose significantly in the intervention group. There were significant decreases in total cholesterol, fasting blood sugar, and C-reactive protein in the supplement group versus placebo group. There was a trend toward reduction in Positive and Negative Syndrome Scale scores with the probiotic supplement, but the difference between the study groups was not statistically significant.
"Targeting the microbiota-gut-brain axis with co-administration of probiotics and vitamin D might provide a novel approach to promote mental health," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Multivitamin Use Not Linked to Mortality Benefit in U.S. Adults
WEDNESDAY, June 26, 2024 -- Multivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online June 26 in JAMA Network...
SNP rs13194504 AA Genotype Linked to Severity of Tardive Dyskinesia
TUESDAY, June 25, 2024 -- For patients with schizophrenia, the single-nucleotide polymorphism (SNP) rs13194504 AA genotype is associated with reduced severity of tardive...
Vitamin D Suggested for Children, Seniors, Those With High-Risk Prediabetes
MONDAY, June 10, 2024 -- Empiric vitamin D supplementation is suggested for those aged 1 to 18 years, those older than 75 years, those who are pregnant, and those with high-risk...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.